NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.410
-0.060 (-2.43%)
At close: Sep 12, 2025, 4:00 PM EDT
2.470
+0.060 (2.49%)
After-hours: Sep 12, 2025, 7:42 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.44 million as of September 12, 2025. Its market cap has increased by 6.00% in one year.
Market Cap
19.44M
Enterprise Value
21.37M
1-Year Change
6.00%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $19.44M, a decrease of -0.75%. That is a compound annual growth rate of -0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 19.44M | -42.01% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |